{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:31:12Z","timestamp":1792812672097,"version":"4.5.0"},"reference-count":28,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T00:00:00Z","timestamp":1741996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>Introduction: Patients with cerebral palsy (CP) present mobility limitations that alter their activity and participation in social life. This study aimed to assess changes in gait kinematic measurements using the Observational Gait Scale (OGS) and preselected parameters related to the foot, knee, and hip in children with CP who received repeated BoNT-A injections within a rehabilitation treatment over a five-year follow-up period. Material and methods: This single-center retrospective observational study included 200 consecutive children with bilateral CP (GMFCS I\u2013IV). The five-year follow-up period was analyzed. Patients received between 5 and 10 BoNT-A treatments (mean 7.6 \u00b1 2.3), with total doses per session varying from 20 units\/kg to 30 units\/kg for ABOBoNT-A and from 10 units\/kg to 20 units\/kg for OnaBoNT-A. In most cases, multilevel injections were performed, including in the hip flexors and adductors, knee flexors, and foot plantar flexors. Results: The mean age of the patients at the beginning was 32.23 months (\u00b16.96). The OGS score improved in 74.5% and 76.5% of the patients, and deterioration occurred in 8.5% and 7% of patients for the right and left lower extremities, respectively. The changes in the OGS typically ranged from 1 to 4 points. Significant improvements in the knee position at midstance, initial foot contact, foot contact at midstance, timing of heel rise, and knee and hip positions at terminal stance were observed. Conclusions: The data from our retrospective observational study show a significant, long-term, positive effect of integrated treatment on gait kinematics in patients with CP in a homogenous group of young children with bilateral spastic cerebral palsy.<\/jats:p>","DOI":"10.3390\/toxins17030142","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T04:29:28Z","timestamp":1742185768000},"page":"142","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Long-Term Improvement of Gait Kinematics in Young Children with Cerebral Palsy Treated with Botulinum Toxin Injections and Integrated\/Intensive Rehabilitation: A 5-Year Retrospective Observational Study"],"prefix":"10.3390","volume":"17","author":[{"given":"Weronika","family":"Pyrzanowska","sequence":"first","affiliation":[{"name":"Health Sciences Department, The Maria Grzegorzewska University, 02-353 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Chro\u015bci\u0144ska-Krawczyk","sequence":"additional","affiliation":[{"name":"Department of Children\u2019s Neurology, University Children\u2019s Hospital, 20-093 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2028-7024","authenticated-orcid":false,"given":"Marcin","family":"Bonikowski","sequence":"additional","affiliation":[{"name":"Health Sciences Department, The Maria Grzegorzewska University, 02-353 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1017\/S001216220500112X","article-title":"Proposed definition and classification of cerebral palsy, April 2005","volume":"47","author":"Bax","year":"2005","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1469-8749.2010.03844.x","article-title":"Distribution of motor types in cerebral palsy: How do registry data compare?","volume":"53","author":"Reid","year":"2011","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"15082","DOI":"10.1038\/nrdp.2015.82","article-title":"Cerebral palsy","volume":"2","author":"Graham","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"158","DOI":"10.5603\/PJNNS.a2021.0032","article-title":"Safety and efficacy of Botulinum toxin type A preparations in cerebral palsy\u2013an evidence-based review","volume":"55","author":"Bonikowski","year":"2021","journal-title":"Neurol. Neurochir. Pol."},{"key":"ref_5","first-page":"161","article-title":"The effects of quantitative gait assessment and botulinum toxin a on musculoskeletal surgery in children with cerebral palsy","volume":"88","author":"Molenaers","year":"2006","journal-title":"J. Bone Jt. Surg."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.apmr.2006.08.342","article-title":"The combined effect of lower-limb multilevel botulinum toxin type a and comprehensive rehabilitation on mobility in children with cerebral palsy: A randomized clinical trial","volume":"87","author":"Scholtes","year":"2006","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.5603\/PJNNS.a2022.0081","article-title":"Functional improvement of young children with cerebral palsy treated with integrated\/intensive rehabilitation and botulinum toxin injections","volume":"57","author":"Bonikowski","year":"2023","journal-title":"Neurol. Neurochir. Pol."},{"key":"ref_8","first-page":"107","article-title":"GMFCS level improvement in children with cerebral palsy treated with repeat botulinum toxin injections and intensive rehabilitation: A retrospective study","volume":"15","author":"Dursun","year":"2022","journal-title":"J. Pediatr. Rehabil. Med."},{"key":"ref_9","first-page":"s23","article-title":"Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with cerebral palsy","volume":"6","author":"Boyd","year":"1999","journal-title":"Eur. J. Neurol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1080\/17518423.2019.1687602","article-title":"Efficacy of Repeat AbobotulinumtoxinA (Dysport\u00ae) Injections in Improving Gait in Children with Spastic Cerebral Palsy","volume":"23","author":"Dursun","year":"2020","journal-title":"Dev. Neurorehabil."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.4103\/ijmr.IJMR_1223_15","article-title":"Effect of multilevel lower-limb botulinum injections & intensive physical therapy on children with cerebral palsy","volume":"146","author":"Juneja","year":"2017","journal-title":"Indian J. Med. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/PHM.0000000000000627","article-title":"Randomized Controlled Trial on Effectiveness of Intermittent Serial Casting on Spastic Equinus Foot in Children with Cerebral Palsy After Botulinum Toxin-A Treatment","volume":"96","author":"Dursun","year":"2017","journal-title":"Am. J. Phys. Med. Rehabil."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1469-8749.2003.tb00852.x","article-title":"Reliability and validity of the Observational Gait Scale in children with spastic diplegia","volume":"45","author":"Mackey","year":"2003","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.pediatrneurol.2005.08.010","article-title":"Botulinum toxin type A for the treatment of the spastic equinus foot in cerebral palsy","volume":"34","author":"Cardoso","year":"2006","journal-title":"Pediatr. Neurol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1542\/peds.108.5.1062","article-title":"Botulinum toxin type a neuromuscular blockade in the treatment of equinus foot deformity in cerebral palsy: A multicenter, open-label clinical trial","volume":"108","author":"Koman","year":"2001","journal-title":"Pediatrics"},{"key":"ref_16","unstructured":"Perry, J., and Burnfield, J.M. (2010). Gait Analysis. Normal and Patological Function, Slack Inc."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1469-8749.2008.03250.x","article-title":"Walking function, pain, and fatigue in adults with cerebral palsy: A 7-year follow-up study","volume":"51","author":"Opheim","year":"2009","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ridd.2018.06.013","article-title":"The natural history of crouch gait in bilateral cerebral palsy: A systematic review","volume":"80","author":"Horgan","year":"2018","journal-title":"Res. Dev. Disabil."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1080\/16501970310018305","article-title":"Musculoskeletal pain in adults with cerebral palsy compared with the general population","volume":"36","author":"Jahnsen","year":"2004","journal-title":"J. Rehabil. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/dmcn.13659","article-title":"Demographic and modifiable factors associated with knee contracture in children with cerebral palsy","volume":"60","author":"Cloodt","year":"2018","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/01241398-199705000-00022","article-title":"The evolution of gait in childhood and adolescent cerebral palsy","volume":"17","author":"Johnson","year":"1997","journal-title":"J. Pediatr. Orthop."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/01241398-200209000-00020","article-title":"Natural progression of gait in children with cerebral palsy","volume":"22","author":"Bell","year":"2002","journal-title":"J. Pediatr. Orthop."},{"key":"ref_23","first-page":"79","article-title":"Prevalence of specific gait abnormalities in children with cerebral palsy: Influence of cerebral palsy subtype, age, and previous surgery","volume":"25","author":"Wren","year":"2005","journal-title":"J. Pediatr. Orthop."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Facciorusso, S., Spina, S., Picelli, A., Baricich, A., Francisco, G.E., Molteni, F., Wissel, J., and Santamato, A. (2024). The Role of Botulinum Toxin Type-A in Spasticity: Research Trends from a Bibliometric Analysis. Toxins, 16.","DOI":"10.3390\/toxins16040184"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/0260106018758519","article-title":"Goal setting for weight-related behavior change in children: An exploratory study","volume":"24","author":"Fisher","year":"2018","journal-title":"Nutr. Health"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s11832-013-0511-x","article-title":"Botulinum toxin A treatment of the lower extremities in children with cerebral palsy","volume":"7","author":"Molenaers","year":"2013","journal-title":"J. Child. Orthop."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1093\/ptj\/80.6.598","article-title":"A multivariate model of determinants of motor change for children with cerebral palsy","volume":"80","author":"Bartlett","year":"2000","journal-title":"Phys. Ther."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1469-8749.2008.02037.x","article-title":"How do changes in body functions and structures, activity, and participation relate in children with cerebral palsy?","volume":"50","author":"Wright","year":"2008","journal-title":"Dev. Med. Child Neurol."}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/17\/3\/142\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:54:15Z","timestamp":1760028855000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/17\/3\/142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,15]]},"references-count":28,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["toxins17030142"],"URL":"https:\/\/doi.org\/10.3390\/toxins17030142","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,15]]}}}